Home › NDC Lookup › RxCUI directory › RxCUI 2599531

Brincidofovir 10 MG/ML Oral Suspension [Tembexa] — RxCUI 2599531

Name: Brincidofovir 10 MG/ML Oral Suspension [Tembexa] (RxCUI 2599531)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2599531 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2599531

Official nameBrincidofovir 10 MG/ML Oral Suspension [Tembexa]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asTembexa 10 MG/ML Oral Suspension

FDA products mapped1

Package NDCs mapped4

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How Brincidofovir 10 MG/ML Oral Suspension [Tembexa] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Brincidofovir 10 MG/ML Oral Suspension [Tembexa] RxCUI 2599531 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Brincidofovir 2599518 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Tembexa 2599526 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Brincidofovir Oral Suspension 2599524 SCDF
- Brincidofovir Oral Liquid Product 2599523 SCDG
- Brincidofovir Oral Product 2599522 SCDG
- Brincidofovir Oral Suspension [Tembexa] 2599530 SBDF
- Tembexa Oral Liquid Product 2599529 SBDG
- Tembexa Oral Product 2599528 SBDG
- Oral Suspension 316969 DF
- Oral Liquid Product 1151137 DFG
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Brincidofovir 10 MG/ML Oral Suspension 2599525 SCD
- Brincidofovir 10 MG/ML 2599521 SCDC
- Brincidofovir 10 MG/ML [Tembexa] 2599527 SBDC

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brincidofovir 10 MG/ML Oral Suspension SCD · 2599525
Brincidofovir 10 MG/ML SCDC · 2599521
Brincidofovir Oral Suspension SCDF · 2599524
Brincidofovir Oral Liquid Product SCDG · 2599523
Brincidofovir Oral Product SCDG · 2599522

Brand-Name Concepts

Brincidofovir 10 MG/ML [Tembexa] SBDC · 2599527
Brincidofovir Oral Suspension [Tembexa] SBDF · 2599530
Tembexa Oral Liquid Product SBDG · 2599529
Tembexa Oral Product SBDG · 2599528
Tembexa BN · 2599526

📦 FDA Products & Package NDCs

1 product · 4 package NDCs

4 package NDCs map to RxCUI 2599531 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
64678-0012-01	65 mL in 1 BOTTLE (64678-012-01)	Tembexa	Emergent BioDefense Operations Lansing LLC	2022-04-20
64678-0012-02	65 mL in 1 BOTTLE (64678-012-02)	Tembexa	Emergent BioDefense Operations Lansing LLC	2022-04-20
64678-0012-03	1 BOTTLE in 1 CARTON (64678-012-03) / 45 mL in 1 BOTTLE	Tembexa	Emergent BioDefense Operations Lansing LLC	2025-07-23
64678-0012-04	1 BOTTLE in 1 CARTON (64678-012-04) / 45 mL in 1 BOTTLE	Tembexa	Emergent BioDefense Operations Lansing LLC	2025-07-23

Observed labelers: Emergent BioDefense Operations Lansing LLC (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.